Cannabis sativa extracts demonstrate potential to in COVID-19 treatment
By Akshay Kedari  Date: 2020-04-23

Cannabis sativa extracts demonstrate potential to in COVID-19 treatment

The University of Lethbridge, with Swysh, a company focused on cannabinoid R&D and Pathway Rx, a research company focused on developing custom cannabis therapies, are partnering to unravel a specific Cannabis sativa extract that shows potential as an additional treatment for the novel coronavirus.

Dr. Igor Kovalchuks, Chief Executive Officer at Pathway RX and Dr. Olga Kovalchuk, (both are professors at The University of Lethbridge) reportedly said that although one of their most successful cannabis sativa extracts require further validation in an animal model as well as in a large-scale analysis, the study is crucial for the examination of the effects of medical cannabis on coronavirus.

A team of researchers and Kovalchuks recently submitted their paper to a journal for publication. The paper represents extensive research study on the effects of medical cannabis on COVID-19. The manuscript of the paper has been uploaded on Preprints. However, it signifies that the research has not yet been peer reviewed or been published in a journal.

As per sources close to the matter, the study is focused on how different cannabis extracts affect TMPRSS2 and ACE2 proteins. These proteins are rooted into the cellular membrane and are the main gateway for the coronavirus to enter host cells. Used by the researchers, the C. sativa has been analyzed for modulating the levels of these enzymes.

Initial data indicate that 13 cannabis sativa extracts which are high in the anti-inflammatory cannabinoid cannabidiol can modulate ACE2 expression in coronavirus target tissues and may also down-regulate TMPRSS2 proteins. The results establish that these high-cannabinoid C. sativa lines showcase potential to be a safe and useful addition for the treatment of COVID-19.

Estimates suggests that they could be potentially utilized to develop preventative treatments in the form of a throat gargle or mouthwash product for clinical as well as home use.

 

Source credit: https://www.uleth.ca/unews/article/u-l-scientists-develop-new-medical-cannabis-cultivars-show-promise-combatting-covid-19-virus#.XqEcDGYzbcu

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

FMCG firms resort to marginal hike to cope with raw material inflation
FMCG firms resort to marginal hike to cope with raw material inflation
By Akshay Kedari

The recent inflation in raw materials has reportedly prompted players in the FMCG sector to take price hike measures for their products, in a bid to maintain the revenues. According to reliable sources, some FMCG companies, including Marico, have al...

boAt raises USD 100 million in funding from Warburg Pincus
boAt raises USD 100 million in funding from Warburg Pincus
By Akshay Kedari

Indian consumer electronics brand, boAt, has reportedly secured funding of USD 100 million from Warburg Pincus, a New-York-based private equity firm, at a USD 300 million valuation. The company will utilize these funds to expand its product portfoli...

Elevar Therapeutics and Inceptua partner to commercialize Apealea®
Elevar Therapeutics and Inceptua partner to commercialize Apealea®
By Akshay Kedari

According to reliable sources, U.S.-based fully integrated biopharmaceutical company, Elevar Therapeutics Inc., has signed an exclusive agreement with Inceptua Group for the commercialization and distribution of its non-cremophor based paclitaxel tre...

NASA completes construction of ‘LC-48’ at Kennedy Space Center
NASA completes construction of ‘LC-48’ at Kennedy Space Center
By Akshay Kedari

The National Aeronautics and Space Administration (NASA) has reportedly announced the completion of the construction of its new launchpad at the Kennedy Space Center based in Florida. Notably, the new Launch Complex 48 or LC-48 is a pad that will be ...

How are energy storage applications driving conductive polymers demand?
How are energy storage applications driving conductive polymers demand?
By Akshay Kedari

With viable environmental stability and mechanical upsides, conductive polymers market players are gearing to infuse funds in the sector. Considered as the 4th generation of polymeric materials, one of the major selling points of conductive polymers ...